Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Chris Lange | Sep 12, 2017 at 10:50 AM EDT

BioCryst Pharmaceuticals Announces Secondary Offering

BioCryst Pharmaceuticals watched its shares fall handily on Tuesday after the firm announced a secondary offering.

Chris Lange | Sep 12, 2017 at 10:20 AM EDT

Sage Therapeutics Gets a Dunce Hat

Sage Therapeutics saw its shares drop by about a quarter early on Tuesday after the firm gave an update on…

Chris Lange | Sep 11, 2017 at 10:50 AM EDT

Can a New CEO Turn Around Teva?

Often companies that lose their way or face adversity may need a change at the top. Teva Pharmaceutical seems to…

Chris Lange | Sep 11, 2017 at 10:35 AM EDT

Marinus Pharma Wins Big With Mid-Stage Epilepsy Study

Marinus Pharmaceuticals saw its shares make a huge gain to kick off the week after the firm announced top-line results…

Chris Lange | Sep 11, 2017 at 8:50 AM EDT

Achillion Pharma Slides After Hep C Deal Is Terminated

Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration…

Chris Lange | Sep 8, 2017 at 10:45 AM EDT

Kura Oncology Doubles on Mid-Stage Trial Results

Kura Oncology saw its shares double early Friday after the firm announced results from its mid-stage trial in patients with…

Chris Lange | Sep 7, 2017 at 12:10 PM EDT

How Bristol-Myers Actually Won by Stopping a Clinical Study

Usually when a clinical study is stopped it spells disaster for the company performing the study, but in this case…

Chris Lange | Sep 7, 2017 at 11:25 AM EDT

Celgene Faces Multiple Clinical Holds From FDA

Celgene received an update from the FDA early on Thursday. Although shares did not dip initially, this action could prove…

Jon C. Ogg | Sep 7, 2017 at 10:35 AM EDT

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Eli Lilly is cutting about 8% of its global workforce in a "streamlining and focusing" effort as part of a…

Chris Lange | Sep 6, 2017 at 1:20 PM EDT

Why Verastem Is Knocking It Out of the Park

Verastem saw perhaps the biggest gain in the market Wednesday after the company announced positive late-stage results.

John Harrington | Sep 6, 2017 at 11:10 AM EDT

Half of Americans Tested Misuse Their Prescription Medications

A study found that while evidence of misuse has declined in recent years, more than half of test results showed…

Chris Lange | Sep 6, 2017 at 10:15 AM EDT

Sarepta Therapeutics Surges Following Duchenne Muscular Dystrophy Trial

Sarepta Therapeutics saw its shares make a handy gain on Wednesday after the firm announced muscle biopsy results from its…

Chris Lange | Sep 6, 2017 at 10:10 AM EDT

Rhythm Pharmaceuticals Files for IPO

Biopharmaceutical company Rhythm Pharmaceuticals has with the SEC regarding its initial public offering.

Chris Lange | Sep 6, 2017 at 8:50 AM EDT

How Insmed Is Capitalizing on Its Huge Late-Stage Success

Insmed has filed with the SEC for a secondary offering. This follows a surge in the share price following positive…

1 … 156 157 158 159 160 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

BioCryst Pharmaceuticals Announces Secondary Offering

Sage Therapeutics Gets a Dunce Hat

Can a New CEO Turn Around Teva?

Marinus Pharma Wins Big With Mid-Stage Epilepsy Study

Achillion Pharma Slides After Hep C Deal Is Terminated

Kura Oncology Doubles on Mid-Stage Trial Results

How Bristol-Myers Actually Won by Stopping a Clinical Study

Celgene Faces Multiple Clinical Holds From FDA

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Why Verastem Is Knocking It Out of the Park

Half of Americans Tested Misuse Their Prescription Medications

Sarepta Therapeutics Surges Following Duchenne Muscular Dystrophy Trial

Rhythm Pharmaceuticals Files for IPO

How Insmed Is Capitalizing on Its Huge Late-Stage Success

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Alphabet, Intel, Micron Lead Nasdaq Higher as Oil Drops on Paused Mideast Tensions

State Street Defense Call Perfectly Tees up Trio Of ETFs For An Incredible 2026

PayPal Tumbles 10% Despite Q1 Earnings Beat: Is the Venmo Spin-off Enough to Save the Stock?

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife

Alphabet, Intel, Micron Lead Nasdaq Higher as Oil Drops on Paused Mideast Tensions

State Street Defense Call Perfectly Tees up Trio Of ETFs For An Incredible 2026

Health and Healthcare Articles

All Health and Healthcare Articles

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

BioCryst Pharmaceuticals Announces Secondary Offering

Sage Therapeutics Gets a Dunce Hat

Can a New CEO Turn Around Teva?

Marinus Pharma Wins Big With Mid-Stage Epilepsy Study

Achillion Pharma Slides After Hep C Deal Is Terminated

Kura Oncology Doubles on Mid-Stage Trial Results

How Bristol-Myers Actually Won by Stopping a Clinical Study

Celgene Faces Multiple Clinical Holds From FDA

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Why Verastem Is Knocking It Out of the Park

Half of Americans Tested Misuse Their Prescription Medications

Sarepta Therapeutics Surges Following Duchenne Muscular Dystrophy Trial

Rhythm Pharmaceuticals Files for IPO

How Insmed Is Capitalizing on Its Huge Late-Stage Success

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Alphabet, Intel, Micron Lead Nasdaq Higher as Oil Drops on Paused Mideast Tensions

State Street Defense Call Perfectly Tees up Trio Of ETFs For An Incredible 2026

PayPal Tumbles 10% Despite Q1 Earnings Beat: Is the Venmo Spin-off Enough to Save the Stock?

Featured Reads

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market

Caleb Hammer Confronts Husband Hiding an AI Girlfriend From His Wife